Form 4 for BSX Boston Scientific
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-18 · accession 0001225208-25-001971 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-19 | 2025-02-18+ | BSX | Sorenson John Bradley | EVP, Gbl Ops | S - Sale | $104.84 | -5,960 | 21.0K | -22% | -$624.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | S | D | 2,657 | $104.41 | 24,294 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-19 | S | D | 3,303 | $105.19 | 20,991 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.365, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |